EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characteristics of [18F]FET PET and MRI in isocitrate dehydrogenase (IDH)-mutant gliomas diagnosed according to the WHO 2021 classification – a retrospective analysis

Enio Barci, Maximilian J Mair, Jonas Reis, Katharina Müller, Jera Isakaj, Ergi Istrefi, Isabelle von Polenz, Sophie C Siegmund, Lena Kaiser, Matthias Preusser, Christian Schichor, Niklas Thon und 4 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2026

DOI: 10.1007/s00259-026-07760-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Enio Barci und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Glioma, Isocitrate Dehydrogenase, Mutation, Magnetic Resonance Imaging. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Klinikum der Universität München.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaIsocitrate DehydrogenaseMutationMagnetic Resonance ImagingTyrosineBrain NeoplasmsPositron-Emission TomographyPositron Emission Tomography Computed TomographyHumansRetrospective StudiesFemaleMiddle AgedMaleAdultAgedWorld Health OrganizationYoung Adult

Stichwörter der Autor:innen

Amino acid PETGliomaMagnetic resonance imagingPositron emission tomography

Substanzen

Isocitrate Dehydrogenase(18F)fluoroethyltyrosineTyrosine

Autor:innen und Institutionen

  • Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
  • Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Institute of Neuroradiology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Bayerisches Zentrum für Krebsforschung (BZKF), partner site Munich, Munich, Germany.
  • Department of Neurosurgery, LMU University Hospital, LMU Munich, Munich, Germany.

ORCID-Profile: Nathalie L Albert

Förderung

  • Klinikum der Universität München

Zitieren

APA

Barci, E., Mair, M. J., Reis, J., Müller, K., Isakaj, J., Istrefi, E., von Polenz, I., Siegmund, S. C., Kaiser, L., Preusser, M., Schichor, C., Thon, N., Harter, P., von Baumgarten, L., Forbrig, R., & Albert, N. L. (2026). Characteristics of [18F]FET PET and MRI in isocitrate dehydrogenase (IDH)-mutant gliomas diagnosed according to the WHO 2021 classification – a retrospective analysis. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-026-07760-2

Vancouver

Barci E, Mair MJ, Reis J, Müller K, Isakaj J, Istrefi E, et al. Characteristics of [18F]FET PET and MRI in isocitrate dehydrogenase (IDH)-mutant gliomas diagnosed according to the WHO 2021 classification – a retrospective analysis. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-026-07760-2

BibTeX
@article{Barci2026,
  author = {Barci, Enio and Mair, Maximilian J and Reis, Jonas and Müller, Katharina and Isakaj, Jera and Istrefi, Ergi and von Polenz, Isabelle and Siegmund, Sophie C and Kaiser, Lena and Preusser, Matthias and Schichor, Christian and Thon, Niklas and Harter, Patrick and von Baumgarten, Louisa and Forbrig, Robert and Albert, Nathalie L},
  title = {Characteristics of [18F]FET PET and MRI in isocitrate dehydrogenase (IDH)-mutant gliomas diagnosed according to the WHO 2021 classification – a retrospective analysis},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  doi = {10.1007/s00259-026-07760-2}
}
Kostenlos starten →